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Um caso de tumor adenomatoide é apresentado. A paciente, uma mulher de 49 anos, foi 
submetida à uma histerectomia vaginal por dor pélvica severa renitente à terapia médica. O 
diagnóstico de tumor adenomatoide foi feito com base na histologia e imunohistoquímica. O 
tumor adenomatoide deve ser considerado como diagnóstico diferencial de leiomiomas em 
























   The adenomatoid tumour (AT) is a rare benign mesothelial proliferation (1). In the genital 
tract it occurs predominantly in the myometrium or fallopian tubes, rarely in the broad 
ligament, the ovary, and the extra genital peritoneum of females and the epididymis, 
spermatic cord, tunica vaginalis and tunica albuginea of males (2). Most AT of the uterus 
present as solitary asymptomatic lesions diagnosed as incidental findings in hysterectomy 
specimens, and multiple AT (mAT) are rare (3). We describe a clinical case of a patient with 




The main goals of this project were: 
1. To do a theoretic review on the theme and all its trends; aetiology, diagnosis, treatment 
and also to report a case.  






After consulting the clinical records of the patient, our first step on approaching the theme 
was a broad search on the internet using the sites Pubmed, Medscape with the following 
keywords; Adenomatoid tumour, Benign uterine tumours, Leiomyoma mimicker, Adenomatoid 
diagnosis, Histoimmunochemical diagnosis of adenomatoid, Treatment of adenomatoid 
tumours. About 30 articles were selected, most of which written in English and Spanish. A 







A case of multiple adenomatoid tumours (mAT) of myometrium is presented. The patient, a 
49-year-old woman underwent vaginal hysterectomy for severe pelvic pain renitent to 
medical therapy. The diagnosis of mAT was made based on histology and in 
immunohistochemistry. AT should be considered in the differential diagnosis with leiomyoma 
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Figure 2- Hematoxylin and Eosin  
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    Although the mesothelial origin have been the most accepted nowadays (4-6), histogenesis 
have been heavily discussed and Endothelial, Müllerian, and Mesonephric origin  have been 
also proposed (7). The term adenomatoid reflects its histologic appearance rather than its 
histogenesis. Golden and Ash suggested an hypothesis that the origin of the tumour, or at 
least, gland-like element of the tumour is composed of epithelial cells due to the tendency of 
these cells to develop vacuoles (8). Allying to Golden and Ash, many authors have also 
considered the AT to be endothelial in origin, accepting the flattened cuboidal appearance of 
the tumour where large spaces are formed as the cell type (8).  
 
    It may well be valid that the common origin of genital mesothelium and Müllerian 
epithelium makes it difficult for us to reach an agreement. In addition, Marcus and Lynn have 
concluded that, microscopically, the evidence to distinguish between the two is inconclusive 
(9, 10). While a Müllerian origin is parallel with the clinical location in both sexes, 
histologically the tumour cells are unlike endometrial or tubal epithelium and have not 
demonstrated evidence of cyclic changes (9, 10). 
 
   The histologic similarity between mesonephric remnants and tumor cells, the stereocilia of 
normal epididymis and the clinical occurrence in males are all consistent with a mesonephric 
hamartomas. However, adenomatoid tumors have never been reported in or around the cervix 
or vagina where mesonephric rests frequently occur. Furthermore, the tumors occur in places 
along the tube and uterus where the embryonic Wolffian duct does not pass, and where 
remnants, therefore, would be unexpected (11). 
 
   The mesothelial aetiology of the AT has also been a source of controversy. Although many 
investigators agree on this hypothesis, recent ultra-structural evidence suggests that some 
adenomatoid tumours may be a vascular neoplasm. A study pursued in 1982 using an 
immunoperoxide method of detecting factor VIII related antigen (a tissue specific marker for 
vascular endothelium) have shown that ATs can be subdivided into tumour of either 
mesothelial or vascular endothelial origin, and both of these groups could be distinguished on 









    To this date, we could not find any theories regarding the pathophysiology of this lesion.   
 
Clinical Presentation and Differential Diagnosis 
     Adenomatoid tumours are usually asymptomatic and frequently are diagnosed after the 
surgery.  
 
   According to a study made by the department of obstetrics and gynaecology of National 
Taiwan University (13) the most frequent preoperative diagnosis of the AT is a Leiomyoma, 
followed by an Adnexal cyst. This coincides with the study created by the Pathology and 
OBGYN department of Clinica Las Condes in Chile which also places Leiomyoma first, 
succeeded by Adenomyosis (2).  
 
   Despite of the fact the AT are benign, and frequently solitary, it has been described cases 
of coexistence with an endometrial adenocarcinoma, and so it may pose a differential 
diagnostic problem in the pathologic staging of the endometrial carcinomas, because of their 
gland-like lumina and infiltration of the myometrium. 
 
   Typically AT are subserosal or located in the outermost zone of myometrium. This is in 
contrast to adenomyosis, where the endometrial glands and stroma infiltrate the 
myometrium. Interestingly, in 1992, was described a case of a diffuse adenomatoid tumour of 
the uterus with a serosal papillary cystic component. The presented woman was undergoing 
immunosuppressive therapy following a kidney transplantation for SLE when a adenomatoid 
tumour diffusely infiltrating the entire myometrium was found containing a serosal papillary 
cystic component that resembled a cystic mesothelioma. This was the first reported case of 
an ATs showing both of these features. Although ATs are considered to be benign, this woman 
would have a 50% risk of recurrence due to the papillary cystic component (14).  
A most recent publication, from 2000, reports a case of a 34-year-old women also undergoing 
immunosuppressive therapy. 
 
   Another interesting case, published in 1986, reports a case of a 25-year-old female with an 
unusual initial presentation of the AT. She underwent dilation and curettage during 
investigation for infertility. The endometrial curettings revealed infiltration of the stroma by 
epithelioid and signet-ring-type tumour cells. Subsequent hysterectomy revealed a large, 
somewhat ill-defined posterior myometrial tumour that on the basis of histological, 
histochemical, and ultra-structural investigation proved to be an adenamatoid tumour with 




               
























Author Clinical findings/ Perioperative diagnosis Main complain 
(16) Incidental NA 
(17) 
Incidental, 32% presumed leiomyoma, 
adenomyosis, endometriosis and unspecified mass NA 
(13) Incidental Infertility (3 cases), NA 
(1) 
Leiomyomas, adenomyosis, endometrial polyp, 
ovarian tumour, uterine prolapse NA 
(18) Leiomyoma, endometriosis Infertility, dysmenorrhea/ menorrhagia 
(3) Leiomyoma Infertility 
(19) Leiomyoma Menorrhagia 
(20) Uterine mass Menorrhagia, pelvic pain 
(21) Uterine prolapse, incidental NA 
(2) Leiomyoma and ovarian teratoma 
Pelvic pain, menorrhagia 
and dysmenorrhea 
(22) Uterine mass Infertility 
(23) Leiomyomas Menorrhagia 
(24) Leiomyomas Menorrhagia 
(7) Incidental, leiomyoma, ovarian cysts Pelvic pain, menorrhagia 
(25) Leiomyoma, ovarian mass Menorrhagia 
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Complementary Methods of Diagnosis 
   As said it before, the adenomatoid tumour are typically asymptomatic. At microscopy, the 
leasion usually has an ill-defined margin with the surrounding myometrium, which helps 
distinguish it from leiomyoma with its distinct margin. However, at MR imaging, the lesion 
may appear as an ill-defined or well-circumscribed mass of low signal intensity on T2-
weighted images, an appearance that can be undistinguishable from that of leiomyoma or 
adenomyoma (26).  
 
   Uncommonly, an adenomatoid tumour has small cystic spaces representing dilated 
mesothelial tubules (Fig. 1) or appears as a large cystic mass (1). 
 
    With that said, to this date, is only possible to diagnose the adenomatoid tumour post 
operation with the help of anatomical pathologic tests. 
 
Anatomical Pathological Diagnosis 
   In order to diagnose lesions of mesothelial origin we have to confirm the presence of at 
least 2 or 3 of the following specific antibodies: AE1/AE3 Cytokeratin, 5/6 Cytokeratin, 
Calretinin, D2/40 and Vimentin (1). Furthermore, we would have to exclude the presence of 
CEA and CD31 (27) and also take into account  the proliferative activity of the lesion with 
help of the proliferation antigen Ki-67 (1). 
 
   Microscopically, AT can be classified into adenomatoid (most common type), angiomatoid, 
solid, or cystic, and combinations of more than one type may occur. The adenomatoid type, 
includes irregular gland-like spaces that are either slit-like or round or cystically dilated (24) 
with absence of outstanding atipia or mitotic activity (28). Occasionally, they are filled out by 
basophyllic material, and can present cytoplasmic vacuolization giving the cells a Signet-ring 
















   Simple excision with uterine conservation is the treatment of choice especially in women 
who desire to be pregnant in the future (29). Successful pregnancy has been reported in 
several cases following surgical excision, which is reassuring to women fertility concerns (3). 
The efficacy of hormonal therapy, which is generally used for treatment of leiomyoma, is 
unclear for AT as patients with this kind of lesions receive this hormonal therapy for 
presumed leiomyomas based on radiological imaging (18). Although two cases of a failed 
pharmacological therapy has been reported (30).   
 
   In 2009, Kalidindi and Odejinmi related two cases in which the tumours were removed 
laparoscopically. They used the harmonic scalpel (Ethicon Endosurgery) to remove as much of 
the tumour as possible including parts of healthy myometrium, because of the lack of lines of 
demarcation of the tumour. This differs from uncomplicated laparoscopic myomectomy where 
the lines of demarcation are clearly identifiable. They also reported some difficulties with 
the myomectomy screws because of the friable nature of the ATs (18). 
 
Prognosis / Post Treatment Vigilance 
   The Adenomatoid tumours have overall a good prognosis, surgery is curative, but recurrence 
has been reported, especially in a case of incomplete excision. In 2005, was reported a case 
of a 33-year-old nulliparous woman with severe menorrhagia and dysmenorrhea, thought to 
be due to a submucosal fibroid on ultrasound. It was later discovered to be 
an adenomatoid tumor, and she underwent surgery, although it was ineffective, as the 
tumour kept recurring.  After one year of continuous attempts to remove the tumour she 
underwent a Strassman procedure, a procedure that consisted in dissection of ureters and 
pelvic vasculature, selective temporary ligation of uterine arteries, hemi section of 
the uterus, and excision of the tumour with frozen sections to ensure clear tumour margins 
and resuturing of the uterine halves. This Temporary vascular occlusion of the uterine 
arteries and ovarian vessels allowed a Strassman procedure, which resulted in successful 
resection of a recurrent giant adenomatoid tumour of the uterus, with fertility preservation 
in a young nulliparous woman. After that, there was no recurrence, 2 years passed and the 
patient is still tumour free (30). To our knowledge this was the only reported case of 











   A 49-year-old multiparous woman presented in our hospital with a severe pelvic pain and 
dyspareunia, with no complains of abnormal uterine bleeding.  
  The patient had an uneventful past medical history except for a Phyllodes tumour 
(Borderline) excision from the left breast. Gynaecologic data: Menarche at the age of 
fourteen, two previous (uneventful) gestations and a regular menstrual cycle (3-4/28 days). 
At that time the patient was taking Lorazepam and pantoprazole daily, but no oral 
contraception.  
   Pelvic examination was normal, except for a slightly enlarged uterus. Pelvic ultrasound 
revealed multiple tumours consistent with leiomyomas.  
   Vaginal hysterectomy was scheduled for treatment of patient symptomatology.  
   On gross examination the uterus measures were: 5. 2 x 5.3 x 4.2cm; weight 87gr. Three 
tumours were identified as yellowish poorly circumscribed intramural nodules, with 
fasciculate appearance and elastic consistency, all located on anterior uterine wall. The 
larger tumour measured 2.4 cm in the largest dimension and the smaller tumour measured 0.9 









Figure 1 Uterus cut surface disclosing three discrete miometrial white nodules (two contiguous-A, and 
another by the serosa-B)   
 
 
   By light microscope all the tumours disclosed tubular structures that dissociate 
myometrium, comprising cuboidal cell without significant atypia and a low mitotic index (Fig 
3). 
 








Figure 2: Uterine adenomatoid tumor: tubular structures dissociating the miometrial smooth muscle (A- 
H&E, x 20); the cells lining the tubules are flat and without atypia (B- H&E, x 100) 
 
 
   By immunohistochemistry the tumour cells express calretinin and keratins (CK8/18) in the 
absence of oestrogen and progesterone receptors expression (Fig 4).  
 
Figure 3- Immunohistochemistry expression of calretinin in the tubular structures of the adenomatoid 
tumor (ABC, x 40) 
 
   No further pathological alterations were found in the specimen. The pathological diagnosis 







   The term Adenomatoid tumours was first proposed by Golden and Ash in 1945 (8) to 
described a benign tumour that morphologically resembles adenomas (18). It’s a rare, non-
recurring, benign mesothelial neoplasms of the genital tract that have been observed in 
women between 30-72 years of age with the median of 42 years (31). The risk of malignant 
transformation is low; only a case of endometrial carcinoma was reported associated with 
adenomatoid tumour of the fallopian tube (32). Our patient is 49 years old, in the range 
reported by previous studies (31).  
    The incidence of adenomatoid tumours in specimens of hysterectomy have been estimate 
to be about 1% (33). Although the true incidence may be greater as these tumours frequently 
are neglected and probably unreported because their small size and similar pathological 
appearance to leiomyomas (14, 34). 
    The histogenesis of adenomatoid tumours remains controversial; it is not uniformly agreed 
whether an adenomatoid tumour is a benign neoplasm or a form of localized mesothelial 
proliferation; mesonephric, mullerian, endothelial, and mesothelial origins have been 
suggested (19). Studies based on transmission electron microscopy, scanning electron 
microscopy, immunohistochemistry, and the typical location of these lesions in genital 
areas/adrenal glands (that have in common their origin from steroidal crest) has supported 
their mesothelial origin. In our case, the immunochemistry expression of keratins (CK8/18) 
and calretinin in the tumour cells supported the mesothelial nature of the mAT. 
   Our patient had complains of severe persistent pelvic pain and dyspareunia, that was the 
reason for vaginal hysterectomy, an unusual presentation described in literature for AT (3). 
Clinically the uterus was discretely enlarged; the pathology report confirmed the small 
volume of the uterus and allowed the diagnosis of AT. Indeed, the diagnosis of adenomatoid 
tumour is usually made as an accidental finding on hysterectomy specimen as in the present 
case (18, 35). 
   According to previous reports, most of AT are solitary tumours.  As reported by others, we 
could not distinguish AT from (the more frequent) leiomyoma of the uterus by clinical 
examination or at ultrasound and so, initially, we suspected of leiomyoma (s). In our case, we 
found three independent AT, all intramural and in the same uterine wall of the surgical 
specimen. Interestingly, the patient had no complains of abnormal uterine haemorrhages. The 
three adenomatoid tumours were separated by normal myometrial tissue.  
Thus, we speculate that the location of the multiple adenomatoid tumours may explain the 








    Table 2- Reports of genital female adenomatoid tumours. NA- Not available. 
Authors/References Nº Cases Age (range) Location 
Size of the 
AT (cm) 
Immunohistochemical Test 




0.6 - 5 .0 
++ Pancytokeratin calretinin 
and HBME-1 + Vimentin 
(17) 32 (Female) 38-79 
Myometrium (26), 
Fallopian tube 
(4), Ovary (2) 
0.1 - 1.6 
++ CKAE1/CAM 5.2, Calretinin, 
D2-40 in 100% of cases and for 
CK5/6 in 16% and Caldesmon in 
3% 
(13) 25 26-55 
Myometrium (23), 
Fallopian tube (2) 
1.0 - 7.0 ++ CK and alcian blue staining 
(1) 32 29-57 Myometrium 0.8 - 4.5 
100% = + CK AE1/AE3, 
Calretinin, Vimentin and D2-40. 
6% = + CK 5/6. 
(18) 2 36-39 Myometrium 6.0 - 7.0 ++ CAM5.2 CK 
(3) 1 39 Myometrium 0.6 - 3.0 
++ CK, CD34, HBME1 and 
Vimentin. 
(19) 1 40 Myometrium 5.2 ++ CK 
(20) 1 39 Fallopian tube 11.0 
++ CK, HBME1, Ca-125(M11) + 
Ca-125 (OC 125) 
(21) 2 36-60 
Myometrium and 
fallopian tube 
2.0 and  
unknown 
++ Calretinin and + CK 
(22) 1 33 Myometrium 5.0 ++ CK and vimentin 
(23) 1 40 Myometrium 6.0 ++ CK AE1-AE3 and calretinin 
(24) 1 43 Myometrium 2.0 ++ CK and calretinin 
(32) 1 60 Fallopian tube 2.0 ++ CK and vimentin 
(7) 2 33 and 36 Myometrium 0.5 - 3.5 NA 
(25) 2 26 and 39 
Myometrium and 
Ovary 
2.5 - 11.5 ++ Calretinin and + for CK 5 
(36) 1 47 Myometrium 2.5 NA 
(37) 1 38 Myometrium 8.0 ++ CK 
(34) 2 unknown Myometrium 12.0 - 13.0 NA 
(38) 9 28-54 
Myometrium (7), 
Fallopian tube 
(1), Ovary (1) 
0.4 - 5.8 ++ Calretinin and CK AE1/AE3 
(39) 24 unknown 
Myometrium (21), 
Ovaries (2) and 
both myometrium 
and ovary (1) 
0.2 - 5.5 
++ Calretinin, Vimentin and CK 
AE1/AE3 
(40) 60 unknown Myometrium 0.2 - 10 





      We report a rare case of a patient with multiple adenomatoid tumours of the 
myometrium, diagnosed after a hysterectomy performed to treat severe and persistent pelvic 
pain and enlarged uterus, interpreted as leiomyoma(s).  Definitive diagnosis was made in the 
pathologic study of the hysterectomy specimen.  
 
    In a patient with severe pelvic pain and an enlarged uterus by multiple tumours, suggesting 




   While performing this review I came across a few flaws that could be improved: Because of 
the rarity of these tumours and its resemblance to leiomyomas many cases go undiagnosed, 
and so it is hard to calculate the true incidence of these tumours. Hence, I would recommend 
a creation of a data base relating these cases. The data base could be lodged in the FCS, in 
other that health science students would have access, and could pursue further studies on the 
matter, for example, a case study regarding the connection between immunosuppressant 
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Abstract: A case of multifocal adenomatoid tumour (mAT) of the myometrium is presented. 
The patient, a 49-year-old woman underwent vaginal hysterectomy for severe pelvic pain 
renitent to medical therapy. The diagnosis of mAT was made based on histology and 
immunohistochemistry. AT should be considered in the differential diagnosis with leiomyoma 
in patients with severe pelvic pain and an enlarged uterus due to multiple nodules. 









   The adenomatoid tumour (AT) is a rare benign mesothelial proliferation (1). In the genital 
tract it occurs predominantly in the myometrium or fallopian tubes, rarely in the broad 
ligament, the ovary, and the extra genital peritoneum of females and the epididymis, 
spermatic cord, tunica vaginalis and tunica albuginea of males (2).  Most AT of the uterus 
present as solitary asymptomatic lesions diagnosed as incidental findings in hysterectomy 
specimens, and multifocal AT (mAT) are rare (3). We describe a clinical case of a patient with 
symptomatic multifocal adenomatoid tumour.  
 
Case Presentation 
   A 49-year-old multiparous woman presented in our hospital with a severe pelvic pain and 
dyspareunia, with no complains of abnormal uterine bleeding. Pelvic examination was normal, 
except for a lightly enlarged uterus.  
Pelvic ultrasound revealed multiple nodules consistent with leiomyoma. Vaginal hysterectomy 
was scheduled for treatment of patient symptomatology. On gross examination the uterus 
weighted 87 gr and measured 5. 2 x 5.3 x 4.2cm. Sections of the uterus disclosed three 
yellowish intramural nodules, with fasciculate appearance and elastic consistency. The larger 
nodule measured 2.4 cm in the largest dimension and the smaller nodule measured 0.9cm 
(Fig. 1 A and B).  
 
   By light microscope all the nodules disclosed tubular structures that dissociate the 
myometrium, comprising flat/cuboidal cells without significant atypia and a low mitotic index 
(Fig 2). By immunohistochemistry the tubular lining cells  expressed calretinin and keratins 
(CK8/18) in the absence of oestrogen and progesterone receptors expression (Fig 3).  
No further pathological alterations were found in the specimen. The pathological diagnosis 








     The term adenomatoid tumour was first proposed by Golden and Ash in 1945 (8) to 
described a benign tumor that morphologically resembles adenomas (18). It is a rare, non-
recurring, benign mesothelial proliferation that has been reported in the genital tract of 
women between 30-72 years of age, with the median of 42 years(31).  The risk of malignant 
transformation is low; only a case of endometrial carcinoma was reported associated with 
adenomatoid tumour of the fallopian tube (32). Our patient is 49 year-old, in the range 
reported in previous studies (31) (Table 1). 
     The incidence of adenomatoid tumours in specimens of hysterectomy have been estimate 
to be ~1% (33). Although the true incidence may be greater as these tumours are frequently 
neglected and probably unreported because of their small size and similar pathological 
appearance to leiomyomas (14, 34).  
   The histogenesis of adenomatoid tumours remains controversial; it is not uniformly agreed 
whether an adenomatoid tumor is a benign neoplasm or a form of localized mesothelial 
proliferation; mesonephric, mullerian, endothelial, and mesothelial origins have been 
suggested (19).  
   Studies based on transmission electron microscopy, scanning electron microscopy, 
immunohistochemistry, and the typical location of these lesions in genital areas/adrenal 
glands (that have in common their origin from steroidal crest) supported their mesothelial 
origin (14, 26, 34, 37, 41). 
   In our case, the immunochemistry expression of keratins (CK8/18) and calretinin in the 
tumour cells supported the mesothelial nature of the mAT. 
   Our patient had complains of severe persistent pelvic pain and dyspareunia, that were the 
reasons for vaginal hysterectomy, an unusual presentation described in literature for AT (3). 
Clinically the uterus was discretely enlarged; the pathology study confirmed the small volume 
of the uterus and allowed the diagnosis of mAT.  
Indeed, the diagnosis of adenomatoid tumor is usually made as an incidental finding on 





   According to previous reports, most of AT are solitary tumours.  As described by others, we 
could not distinguish mAT from (the more frequent) multiple leiomyoma of the uterus by 
clinical examination or at ultrasound and so, initially, we suspected of multiple leiomyoma. In 
our case, we found a multifocal AT. Interestingly, the patient had no complains of abnormal 
uterine haemorrhages.  
   Since the adenomatoid tumour was multifocal in the present case, we speculate that the 
dimension and location of the adenomatoid tumour nodules may explain the painful 





















Table 1 - Reports of genital female adenomatoid tumours. NA- Not available.    
 
      
Authors/References Nº Cases Age (range) Location 
Size of the 
AT (cm) 
Immunohistochemical Test 




0.6 - 5 .0 
++ Pancytokeratin calretinin 
and HBME-1 + Vimentin 
(17) 32 (Female) 38-79 
Myometrium (26), 
Fallopian tube 
(4), Ovary (2) 
0.1 - 1.6 
++ CKAE1/CAM 5.2, Calretinin, 
D2-40 in 100% of cases and for 
CK5/6 in 16% and Caldesmon in 
3% 
(13) 25 26-55 
Myometrium (23), 
Fallopian tube (2) 
1.0 - 7.0 ++ CK and alcian blue staining 
(1) 32 29-57 Myometrium 0.8 - 4.5 
100% = + CK AE1/AE3, 
Calretinin, Vimentin and D2-40. 
6% = + CK 5/6. 
(18) 2 36-39 Myometrium 6.0 - 7.0 ++ CAM5.2 CK 
(3) 1 39 Myometrium 0.6 - 3.0 
++ CK, CD34, HBME1 and 
Vimentin. 
(19) 1 40 Myometrium 5.2 ++ CK 
(20) 1 39 Fallopian tube 11.0 
++ CK, HBME1, Ca-125(M11) + 
Ca-125 (OC 125) 
(21) 2 36-60 
Myometrium and 
fallopian tube 
2.0 and  
unknown 
++ Calretinin and + CK 
(22) 1 33 Myometrium 5.0 ++ CK and vimentin 
(23) 1 40 Myometrium 6.0 ++ CK AE1-AE3 and calretinin 
(24) 1 43 Myometrium 2.0 ++ CK and calretinin 
(32) 1 60 Fallopian tube 2.0 ++ CK and vimentin 
(7) 2 33 and 36 Myometrium 0.5 - 3.5 NA 
(25) 2 26 and 39 
Myometrium and 
Ovary 
2.5 - 11.5 ++ Calretinin and + for CK 5 
(36) 1 47 Myometrium 2.5 NA 
(37) 1 38 Myometrium 8.0 ++ CK 
(34) 2 unknown Myometrium 12.0 - 13.0 NA 
(38) 9 28-54 
Myometrium (7), 
Fallopian tube 
(1), Ovary (1) 
0.4 - 5.8 ++ Calretinin and CK AE1/AE3 
(39) 24 unknown 
Myometrium (21), 
Ovaries (2) and 
both myometrium 
and ovary (1) 
0.2 - 5.5 
++ Calretinin, Vimentin and CK 
AE1/AE3 
(40) 60 unknown Myometrium 0.2 - 10 





















Author Clinical findings/ Perioperative diagnosis Main complain 
(16) Incidental NA 
(17) 
Incidental, 32% presumed leiomyoma, 
adenomyosis, endometriosis and unspecified mass 
NA 
(13) Incidental Infertility (3 cases), NA 
(1) 
Leiomyomas, adenomyosis, endometrial polyp, 
ovarian tumour, uterine prolapse 
NA 
(18) Leiomyoma, endometriosis Infertility, dysmenorrhea/ menorrhagia 
(3) Leiomyoma Infertility 
(19) Leiomyoma Menorrhagia 
(20) Uterine mass Menorrhagia, pelvic pain 
(21) Uterine prolapse, incidental NA 
(2) Leiomyoma and ovarian teratoma 
Pelvic pain, menorrhagia 
and dysmenorrhea 
(22) Uterine mass Infertility 
(23) Leiomyomas Menorrhagia 
(24) Leiomyomas Menorrhagia 
(7) Incidental, leiomyoma, ovarian cysts Pelvic pain, menorrhagia 
(25) Leiomyoma, ovarian mass Menorrhagia 




   We report a rare case of a patient with a multifocal adenomatoid tumour of the 
myometrium, diagnosed after a hysterectomy performed to treat severe and persistent pelvic 
pain and enlarged uterus, interpreted as multiple leiomyoma.  Definitive diagnosis was made 
in the pathologic study of the hysterectomy specimen.  
   In a patient with severe pelvic pain and an enlarged uterus by multiple nodules, suggesting 
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Figure 1 Uterus cut surface disclosing three discrete miometrial white nodules (two 









Figure 2: Uterine adenomatoid tumor: tubular structures dissociating the miometrial smooth 





Figure 3: Immunohistochemistry expression of calretinin in the tubular structures of the 
adenomatoid tumor (ABC, x 40) 
 
